Supplemental fibrinogen restores thrombus formation in cardiopulmonary bypass-induced platelet dysfunction ex vivo

[1]  N. Rahe-meyer,et al.  Efficacy of platelet transfusion in cardiac surgery , 2022, Platelets.

[2]  A. Michelson,et al.  Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency , 2020, Journal of thrombosis and haemostasis : JTH.

[3]  K. Karkouti,et al.  Managing the coagulopathy associated with cardiopulmonary bypass , 2020, Journal of thrombosis and haemostasis : JTH.

[4]  E. Mahla,et al.  Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study , 2020, Thrombosis and Haemostasis.

[5]  M. Lordkipanidzé,et al.  Advances in Platelet Function Testing—Light Transmission Aggregometry and Beyond , 2020, Journal of clinical medicine.

[6]  S. Verma,et al.  Platelet Transfusion in Cardiac Surgery: A Systematic Review and Meta-Analysis. , 2020, The Annals of thoracic surgery.

[7]  Raja R. Palvadi,et al.  Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. , 2019, Anesthesia and analgesia.

[8]  K. Kaikita,et al.  Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease , 2019, Thrombosis and Haemostasis.

[9]  J. Airaksinen,et al.  Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting. , 2019, The Annals of thoracic surgery.

[10]  G. Faggian,et al.  Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting , 2019, Platelets.

[11]  V. Rao,et al.  Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials: Universal Definition of Perioperative Bleeding in Cardiac Surgery and European Coronary Artery Bypass Grafting Bleeding Severity Grade , 2018, Anesthesiology.

[12]  L. Menicanti,et al.  Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study , 2018, Platelets.

[13]  G. Faggian,et al.  Variation in preoperative antithrombotic strategy, severe bleeding, and use of blood products in coronary artery bypass grafting: results from the multicentre E-CABG registry , 2018, European heart journal. Quality of care & clinical outcomes.

[14]  A. Camm,et al.  The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. , 2018, European heart journal.

[15]  J. Hammon,et al.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass. , 2018, The journal of extra-corporeal technology.

[16]  S. Silvetti,et al.  Fibrinogen levels compensation of thrombocytopenia-induced bleeding following cardiac surgery. , 2017, International journal of cardiology.

[17]  J. Airaksinen,et al.  Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery. , 2017, Journal of cardiothoracic and vascular anesthesia.

[18]  D. von Lewinski,et al.  Implementation of buffy‐coat‐derived pooled platelet concentrates for internal quality control of light transmission aggregometry: a proof of concept study , 2017, Journal of thrombosis and haemostasis : JTH.

[19]  R. Rossaint,et al.  What is the evidence for platelet transfusion in perioperative settings? , 2017, Vox sanguinis.

[20]  A. Koster,et al.  2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. , 2017, Journal of cardiothoracic and vascular anesthesia.

[21]  A. Nierich,et al.  Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial , 2017, JAMA.

[22]  R. Bellomo,et al.  Is platelet transfusion associated with hospital-acquired infections in critically ill patients? , 2017, Critical Care.

[23]  A. Berghold,et al.  Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy? , 2016, The Annals of thoracic surgery.

[24]  M. Hermann,et al.  Fibrinogen supplementation ex vivo increasesclot firmness comparable to platelet transfusion in thrombocytopenia. , 2016, British journal of anaesthesia.

[25]  V. Rao,et al.  Point-of-Care Hemostatic Testing in Cardiac Surgery: A Stepped-Wedge Clustered Randomized Controlled Trial. , 2016, Circulation.

[26]  Y. Okita,et al.  Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. , 2016, British journal of anaesthesia.

[27]  T. Stijnen,et al.  Hemostatic alterations during coronary artery bypass grafting. , 2016, Thrombosis research.

[28]  L. Menicanti,et al.  Randomized, Double-Blinded, Placebo-Controlled Trial of Fibrinogen Concentrate Supplementation After Complex Cardiac Surgery , 2015, Journal of the American Heart Association.

[29]  L. Goodnough,et al.  Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy , 2014, Transfusion.

[30]  S. McCluskey,et al.  Platelet Dysfunction as Measured by a Point-of-Care Monitor is an Independent Predictor of High Blood Loss in Cardiac Surgery , 2014, Anesthesia and analgesia.

[31]  F. Szlam,et al.  Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. , 2013, British journal of anaesthesia.

[32]  A. Schmaier,et al.  Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH , 2013, Journal of thrombosis and haemostasis : JTH.

[33]  Y. Dargaud,et al.  Mechanisms and monitoring of bypassing agent therapy , 2012, Journal of thrombosis and haemostasis : JTH.

[34]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[35]  B. Balkau,et al.  Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. , 2012, British journal of anaesthesia.

[36]  M. Hickey,et al.  Evidence of Platelet Activation at Medically Used Hypothermia and Mechanistic Data Indicating ADP as a Key Mediator and Therapeutic Target , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[37]  T. Haas,et al.  Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. , 2005, British journal of anaesthesia.

[38]  P. Thiagarajan,et al.  P-Selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates , 2000, Circulation.

[39]  R. Hillman,et al.  Platelet activation and aggregation during cardiopulmonary bypass. , 1991, Anesthesiology.

[40]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[41]  J. Joist,et al.  Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. , 1984, Blood.